Molecules in the tryptophan-5-hydroxytryptophan-serotonin-NAS-melatonin/6-hydroxymelatonin sulfate-melatonin receptor 1A pathway in neurological diseases
US10507199B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 8, 2018 |
| Grant date | Dec 17, 2019 |
| Priority date | — |
| Expiry date | May 8, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7038
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods that include determining levels of melatonin pathway agents (melatonin, L-tryptophan, 5-hydroxytryptophan (5-HTP), serotonin, N-acetylserotonin (NAS), and melatonin receptor 1A (MT1)) in Hypoxic-ischemic brain injury in both newborns (HIE) and adults (stroke), and in ALS, and optionally administering these agents to treat these conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.